Staff Nephrologist and Clinician Investigator @UHN; Associate Professor of Medicine @UofT_DoM; Interested in #Onconephrology #AKI
Toronto, Ontario
Joined June 2018
- Tweets1.2K
- Following563
- Followers1.1K
- Likes3.4K
Abhijat Kitchlu | Onconephrology retweeted
📍 Happening now at @ASNKidney KidneyWeek in Denver!
Join us for the ASN OncoNephrology Program for a day of cutting-edge science, emerging cancer therapies, and practical insights.
Are your ready? 🫘
@onconeph @rc_oncneph @SheronLatcha @ShrutiGkidney @PaulHannaMD @hhashmi87
Abhijat Kitchlu | Onconephrology retweeted
Early Program in Onconephrology 2026: Novel radioligand therapies and nephrotocixity by @rc_oncneph Dr. Raad Chowdhury. @MGBKidneys Alpha- and beta-particle related toxicity to kidneys: important to recognize🚨 @ASNKidney @onconephsociety #KidneyWk
Abhijat Kitchlu | Onconephrology retweeted
Early Program: Onconephrology in 2026 @ASNKidney is starting!!
Dr. Hamza Hashmi discussing progress of therapies for patients with plasma cell dyscrasia 🦀
Historical insights, novel therapies- survival for myeloma improved >20 years over the last decade! #KidneyWk
Abhijat Kitchlu | Onconephrology retweeted
Our course ends with a blockbuster !! 💥
When should we biopsy immune checkpoint inhibitor associated AKI? And should ESAs be avoided in patients with cancer? Two practical questions, discussed through cases and debate.
@PaulHannaMD @virginieroyal @rc_oncneph @ShrutiGkidney
Abhijat Kitchlu | Onconephrology retweeted
Can we identify patients at risk of AKI before it happens? This session by Gabrielle Côté will discuss risk scores, nephroprotective strategies and rescue treatments for AKI related to cytotoxic cancer therapies.
✨Are you at Denver already!?
@rc_oncneph @onconeph
Abhijat Kitchlu | Onconephrology retweeted
Immune checkpoint inhibitors keep emerging, they’ve changed cancer treatment, but many questions remain for nephrologists.
@ShrutiGkidney, looks at biomarkers, imaging and the challenging question of rechallenge after toxicity.
@rc_oncneph @MGBKidneys
Abhijat Kitchlu | Onconephrology retweeted
How much kidney function is enough for the right dose?
This session by @PaulHannaMD and Thomas Nolin looks at individualising GFR assessment and multidisciplinary dose adjustment of anticancer therapies in CKD and ESKD.
@rc_oncneph @onconeph @SheronLatcha @ShrutiGkidney
Abhijat Kitchlu | Onconephrology retweeted
Pathology Case Based Review: Paraneoplastic Glomerular Diseases
A pathology focused session by @virginieroyal, with case based discussion of the patterns that can help us connect the kidney findings with the underlying malignancy.
@rc_oncneph @SheronLatcha @onconeph
Abhijat Kitchlu | Onconephrology retweeted
🩸Thrombotic Microangiopathy in Patients with Cancer 🩸
Cancer associated TMA can be complex, especially when complement activation is involved.
This session by @anuja_java will explore the role of complement regulation and inhibition in these patients.
@rc_oncneph @onconeph
Abhijat Kitchlu | Onconephrology retweeted
The ASN Kidney week’s @ASNKidney onconephrology program promises some amazing sessions, discussion on cutting edge treatments, and fiery case discussions !!
Still not registered ?
⏰Now’s the time to do it !!
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney
Abhijat Kitchlu | Onconephrology retweeted
Our next session?
🩺Case Based Debates in Onconephrology ➡️ To Transplant or Not to Transplant in patients with cancers ?
Discussants : Nadia Al Haddad, @hhashmi87 @anuja_java @nymurakami @itunuowoyemi
Register 🔗: asn-online.org/education/kid…
@rc_oncneph @onconeph @SheronLatcha
Abhijat Kitchlu | Onconephrology retweeted
🦀🫘👩🏻⚕️Kidney Transplant Onconephrology
How do we approach cancer treatment in KTRs?
Dr Murakami @nymurakami discusses immunotherapy, engineered cellular therapies and management of PTLDs
Register 🔗 : asn-online.org/education/kid…
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney
Abhijat Kitchlu | Onconephrology retweeted
✨Session 4: AKI and Electrolyte Disturbances in Cancer and Novel Targeted Therapies
Cancer therapies continue to evolve, and so do the kidney complications we see with them.
🎙️ : @ZiolkowskiSusan
@onconeph @SheronLatcha @MaulinPatelDO
Register : asn-online.org/education/kid…
Abhijat Kitchlu | Onconephrology retweeted
Next off, we discuss Novel Radioligand Therapies and Nephrotoxicity
This session by @rc_oncneph will focus on these newer therapies and an important question for nephrologists: what do we need to know about their renal effects?
@onconeph @SheronLatcha @ShrutiGkidney
Abhijat Kitchlu | Onconephrology retweeted
Update on Paraproteinemia and Kidney Pathologies: Monoclonal vs. Monotypic
This session by Lihong Bu will look at monoclonal vs. monotypic patterns and the renal pathologies we need to recognise.
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney
Abhijat Kitchlu | Onconephrology retweeted
#TheWeeklyNephron is back! 🧵
This time, an important topic: anemia in patients with cancer + CKD.
🧵by @DrAkshayaJ
The ASON @onconephsociety position statement is not yet formally published, but the pre-proof is available, at @Kidney_Int and I thought this was too important not to discuss.
✍️ @SwethaKanduriMD @LaylaVanDoren @Shuchi_Anand @PAmarapurkar @stefanie_benoit @basmeomeo @delphile @anushreeshirali @claudebassil @HerrmannMd @onconeph @esesemo
Let’s look at the practical takeaways 👇
Abhijat Kitchlu | Onconephrology retweeted
See below for some highlights for the upcoming pre course @ASNKidney #kidneyweek2026 on @onconephsociety
Plasma Cell Dyscrasias and Engineered Cellular Therapy: Is a Cure in Sight?
💉We’ll have a look at how these newer treatments are changing the landscape of cancer care and what they mean for the kidney. 🫘
🎙️@hhashmi87
👥@onconeph @SheronLatcha
@ASNKidney @rc_oncneph
